150 related articles for article (PubMed ID: 18789701)
21. Intracellular substrates for the primer-unblocking reaction by human immunodeficiency virus type 1 reverse transcriptase: detection and quantitation in extracts from quiescent- and activated-lymphocyte subpopulations.
Smith AJ; Meyer PR; Asthana D; Ashman MR; Scott WA
Antimicrob Agents Chemother; 2005 May; 49(5):1761-9. PubMed ID: 15855493
[TBL] [Abstract][Full Text] [Related]
22. Effects of beta-L-3'-azido-3'-deoxythymidine 5'-triphosphate on host and viral DNA polymerases.
Faraj A; El Alaoui AM; Gosselin G; Imbach JL; Morrow C; Sommadossi JP
Antiviral Res; 2000 Aug; 47(2):97-102. PubMed ID: 10996397
[TBL] [Abstract][Full Text] [Related]
23. Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by alpha-phosphate-modified thymidine analogues.
Matamoros T; Deval J; Guerreiro C; Mulard L; Canard B; Menéndez-Arias L
J Mol Biol; 2005 Jun; 349(3):451-63. PubMed ID: 15878178
[TBL] [Abstract][Full Text] [Related]
24. The 3'-azido group is not the primary determinant of 3'-azido-3'-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1.
Sluis-Cremer N; Arion D; Parikh U; Koontz D; Schinazi RF; Mellors JW; Parniak MA
J Biol Chem; 2005 Aug; 280(32):29047-52. PubMed ID: 15970587
[TBL] [Abstract][Full Text] [Related]
25. Synergistic inhibition of HIV-1 reverse transcriptase by combinations of chain-terminating nucleotides.
Villahermosa ML; Martinez-Irujo JJ; Cabodevilla F; Santiago E
Biochemistry; 1997 Oct; 36(43):13223-31. PubMed ID: 9341211
[TBL] [Abstract][Full Text] [Related]
26. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase.
Meyer PR; Matsuura SE; Mian AM; So AG; Scott WA
Mol Cell; 1999 Jul; 4(1):35-43. PubMed ID: 10445025
[TBL] [Abstract][Full Text] [Related]
27. Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors.
Mas A; Vázquez-Alvarez BM; Domingo E; Menéndez-Arias L
J Mol Biol; 2002 Oct; 323(2):181-97. PubMed ID: 12381314
[TBL] [Abstract][Full Text] [Related]
28. In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.
Dianzani F; Antonelli G; Turriziani O; Dong G; Capobianchi MR; Riva E
Antiviral Res; 1992 May; 18(1):39-52. PubMed ID: 1384427
[TBL] [Abstract][Full Text] [Related]
29. Application of a colorimetric chain-termination assay for characterization of reverse transcriptase from 3'-azido-2',3'-deoxythymidine-resistant HIV isolates.
Shao XW; Hjalmarsson S; Lennerstrand J; Svennerholm B; Blomberg J; Källander CF; Gronowitz JS
Biotechnol Appl Biochem; 2002 Jun; 35(3):155-64. PubMed ID: 12074693
[TBL] [Abstract][Full Text] [Related]
30. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.
Marchand B; White KL; Ly JK; Margot NA; Wang R; McDermott M; Miller MD; Götte M
Antimicrob Agents Chemother; 2007 Aug; 51(8):2911-9. PubMed ID: 17517852
[TBL] [Abstract][Full Text] [Related]
31. Metabolic transformation of AZTp4A by Ap4A hydrolase regenerates AZT triphosphate.
Pitcher WH; Kirby TW; DeRose EF; London RE
Antiviral Res; 2003 May; 58(3):227-33. PubMed ID: 12767470
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for the efficient phosphorylation of AZT-MP (3'-azido-3'-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase.
Whittingham JL; Carrero-Lerida J; Brannigan JA; Ruiz-Perez LM; Silva AP; Fogg MJ; Wilkinson AJ; Gilbert IH; Wilson KS; González-Pacanowska D
Biochem J; 2010 May; 428(3):499-509. PubMed ID: 20353400
[TBL] [Abstract][Full Text] [Related]
33. Electrochemical reduction products of azido nucleosides, including zidovudine (AZT): mechanisms and relevance to their intracellular metabolism.
Kawczyński W; Czochralska B; Shugar D
Acta Biochim Pol; 1993; 40(2):213-23. PubMed ID: 8212958
[TBL] [Abstract][Full Text] [Related]
34. Conformation and local environment of nucleotides bound to HIV type 1 reverse transcriptase (HIV-1 RT) in the ground state.
Painter GR; Andrews CW; Furman PA
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):13-29. PubMed ID: 10772700
[TBL] [Abstract][Full Text] [Related]
35. Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants.
Lennerstrand J; Hertogs K; Stammers DK; Larder BA
J Virol; 2001 Aug; 75(15):7202-5. PubMed ID: 11435603
[TBL] [Abstract][Full Text] [Related]
36. Substrate mimicry: HIV-1 reverse transcriptase recognizes 6-modified-3'-azido-2',3'-dideoxyguanosine-5'-triphosphates as adenosine analogs.
Herman BD; Schinazi RF; Zhang HW; Nettles JH; Stanton R; Detorio M; Obikhod A; Pradère U; Coats SJ; Mellors JW; Sluis-Cremer N
Nucleic Acids Res; 2012 Jan; 40(1):381-90. PubMed ID: 21914723
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of 5'-triphosphate mimics (P3Ms) of 3'-azido-3',5'-dideoxythymidine and 3',5'-dideoxy-5'-difluoromethylenethymidine as HIV-1 reverse transcriptase inhibitors.
Rajwanshi VK; Prhavc M; Fagan P; Brooks JL; Hurd T; Cook PD; Wang G
Nucleosides Nucleotides Nucleic Acids; 2005; 24(3):179-89. PubMed ID: 15892257
[TBL] [Abstract][Full Text] [Related]
39. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
Wińska P; Miazga A; Poznański J; Kulikowski T
Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
Jaju M; Beard WA; Wilson SH
J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
